Joanne Quan's most recent trade in Mirum Pharmaceuticals Inc was a trade of 40,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals Inc | Joanne Quan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
Mirum Pharmaceuticals Inc | Joanne Quan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
Mirum Pharmaceuticals Inc | Joanne Quan | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 12,500 | 25,000 | - | - | Restricted Stock Units | |
Mirum Pharmaceuticals Inc | Joanne Quan | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 12,500 | 12,618 (0%) | 0% | - | Common Stock | |
Mirum Pharmaceuticals Inc | Joanne Quan | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.86 per share. | 16 Jan 2025 | 6,969 | 5,649 (0%) | 0% | 45.9 | 319,598 | Common Stock |
Mirum Pharmaceuticals Inc | Joanne Quan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 21.04 per share. | 08 Nov 2024 | 118 | 118 (0%) | 0% | 21.0 | 2,483 | Common Stock |
Mirum Pharmaceuticals Inc | Joanne Quan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
Mirum Pharmaceuticals Inc | Joanne Quan | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 37,500 | 37,500 | - | - | Restricted Stock Units |